AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sugarace GB 2.5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Inavars Biologicals Inc

Salt Composition

Glimepiride (2.5mg) + Metformin (500mg)

Overview Sugarace GB 2.5mg/500mg Tablet

Diabetace Duo 2.5mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This formulation helps regulate blood glucose in diabetic patients. Diabetace Duo 2.5mg/500mg tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can elevate glucose levels, risking complications such as kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor; lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals, carry readily-available glucose (e.g., sugary snacks, juice), and avoid alcohol to mitigate this risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) will be recommended by your doctor.

Primary Ingredients of Sugarace GB 2.5mg/500mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Sugarace GB 2.5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sugarace GB 2.5mg/500mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sugarace GB 2.5mg/500mg tablets with a meal.

Common Side effects of Sugarace GB 2.5mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Sugarace GB 2.5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sugarace GB 2.5mg/500mg Tablet whole; do not chew, crush, or divide it. Administer this medicine with a meal.

How Sugarace GB 2.5mg/500mg Tablet works:

Each Sugarace GB 2.5mg/500mg tablet unites glimepiride (a sulfonylurea) and metformin (a biguanide), two agents that combat elevated blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin acts triply: decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sugarace GB 2.5mg/500mg Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sugarace GB 2.5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Sugarace GB 2.5mg/500mg tablets due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use the 2.5mg/500mg Sugarace GB tablet cautiously, potentially requiring dosage modification. Consult your physician for guidance. The 2.5mg/500mg Sugarace GB tablet is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Sugarace GB 2.5mg/500mg Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate hepatic dysfunction, Sugarace GB 2.5mg/500mg Tablets are typically initiated at a reduced dosage; however, their use is contraindicated in patients with severe liver disease.

What if you forget to take Sugarace GB 2.5mg/500mg Tablet :

Should you forget to take your Sugarace GB 2.5mg/500mg Tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Sugarace GB 2.5mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sugarace GB 2.5mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sugarace GB 2.5mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue use and seek immediate medical attention.
Sugarace GB 2.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 DM.
Sugarace GB 2.5mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Sugarace GB 2.5mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Indeed, Sugarace GB 2.5mg/500mg Tablets can lower blood sugar, potentially causing hypoglycemia. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness may occur, especially if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other diabetes medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Sugarace GB 2.5mg/500mg Tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Sugarace GB 2.5mg/500mg T...
125
MRP 152
17% off